Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 927

1.

The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.

Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, Renauld JC, Vosshenrich CA, Di Santo JP.

J Immunol. 2009 Nov 15;183(10):6579-87. doi: 10.4049/jimmunol.0901935. Epub 2009 Oct 21.

PMID:
19846871
[PubMed - indexed for MEDLINE]
Free Article
2.

Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.

Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP.

Immunity. 2008 Dec 19;29(6):958-70. doi: 10.1016/j.immuni.2008.11.001. Epub 2008 Dec 11.

PMID:
19084435
[PubMed - indexed for MEDLINE]
Free Article
3.

IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.

Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich CA, Di Santo JP.

J Exp Med. 2010 Feb 15;207(2):273-80. doi: 10.1084/jem.20092029. Epub 2010 Feb 8.

PMID:
20142427
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells.

Satoh-Takayama N, Lesjean-Pottier S, Sawa S, Vosshenrich CA, Eberl G, Di Santo JP.

Eur J Immunol. 2011 Mar;41(3):780-6. doi: 10.1002/eji.201040851. Epub 2011 Feb 1.

PMID:
21341264
[PubMed - indexed for MEDLINE]
5.

Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

Takayama T, Kamada N, Chinen H, Okamoto S, Kitazume MT, Chang J, Matuzaki Y, Suzuki S, Sugita A, Koganei K, Hisamatsu T, Kanai T, Hibi T.

Gastroenterology. 2010 Sep;139(3):882-92, 892.e1-3. doi: 10.1053/j.gastro.2010.05.040. Epub 2010 Jun 1.

PMID:
20638936
[PubMed - indexed for MEDLINE]
6.

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

Halfteck GG, Elboim M, Gur C, Achdout H, Ghadially H, Mandelboim O.

J Immunol. 2009 Feb 15;182(4):2221-30. doi: 10.4049/jimmunol.0801878.

PMID:
19201876
[PubMed - indexed for MEDLINE]
Free Article
7.

Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.

Glasner A, Ghadially H, Gur C, Stanietsky N, Tsukerman P, Enk J, Mandelboim O.

J Immunol. 2012 Mar 15;188(6):2509-15. doi: 10.4049/jimmunol.1102461. Epub 2012 Feb 3.

PMID:
22308311
[PubMed - indexed for MEDLINE]
Free Article
8.

Isolation of NK cells and NK-like cells from the intestinal lamina propria.

Sanos SL, Diefenbach A.

Methods Mol Biol. 2010;612:505-17. doi: 10.1007/978-1-60761-362-6_32.

PMID:
20033661
[PubMed - indexed for MEDLINE]
9.

TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.

Mielke LA, Groom JR, Rankin LC, Seillet C, Masson F, Putoczki T, Belz GT.

J Immunol. 2013 Oct 15;191(8):4383-91. doi: 10.4049/jimmunol.1301228. Epub 2013 Sep 13.

PMID:
24038093
[PubMed - indexed for MEDLINE]
10.

CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells.

Vosshenrich CA, Lesjean-Pottier S, Hasan M, Richard-Le Goff O, Corcuff E, Mandelboim O, Di Santo JP.

J Exp Med. 2007 Oct 29;204(11):2569-78. Epub 2007 Oct 8.

PMID:
17923507
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.

Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d'Hargues Y, Göppert N, Croxford AL, Waisman A, Tanriver Y, Diefenbach A.

Nature. 2013 Feb 14;494(7436):261-5. doi: 10.1038/nature11813. Epub 2013 Jan 16.

PMID:
23334414
[PubMed - indexed for MEDLINE]
12.

IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation.

Ohta N, Hiroi T, Kweon MN, Kinoshita N, Jang MH, Mashimo T, Miyazaki J, Kiyono H.

J Immunol. 2002 Jul 1;169(1):460-8.

PMID:
12077277
[PubMed - indexed for MEDLINE]
Free Article
13.

Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin.

Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D, Dalod M, Littman DR, Vivier E, Tomasello E.

Nat Immunol. 2009 Jan;10(1):75-82. doi: 10.1038/ni.1681. Epub 2008 Nov 23.

PMID:
19029904
[PubMed - indexed for MEDLINE]
14.

CD3⁻NK1.1⁺ cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen.

Reid-Yu SA, Small CL, Coombes BK.

Eur J Immunol. 2013 Oct;43(10):2638-49. doi: 10.1002/eji.201343435. Epub 2013 Jul 12.

PMID:
23775576
[PubMed - indexed for MEDLINE]
15.

Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia.

Xu X, Weiss ID, Zhang HH, Singh SP, Wynn TA, Wilson MS, Farber JM.

J Immunol. 2014 Feb 15;192(4):1778-86. doi: 10.4049/jimmunol.1300039. Epub 2014 Jan 17.

PMID:
24442439
[PubMed - indexed for MEDLINE]
16.

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W.

Nat Med. 2008 Mar;14(3):282-9. doi: 10.1038/nm1720. Epub 2008 Feb 10.

PMID:
18264109
[PubMed - indexed for MEDLINE]
17.

Differentiation of murine NK cells into distinct subsets based on variable expression of the IL-12R beta 2 subunit.

Chakir H, Camilucci AA, Filion LG, Webb JR.

J Immunol. 2000 Nov 1;165(9):4985-93.

PMID:
11046026
[PubMed - indexed for MEDLINE]
Free Article
18.

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22.

Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, Littman DR, O'Shea JJ.

J Exp Med. 2009 Jan 16;206(1):35-41. doi: 10.1084/jem.20072713. Epub 2008 Dec 29.

PMID:
19114665
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Natural killer receptors: the burden of a name.

Veiga-Fernandes H, Kioussis D, Coles M.

J Exp Med. 2010 Feb 15;207(2):269-72. doi: 10.1084/jem.20100105. Epub 2010 Feb 8.

PMID:
20142428
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Receptors for non-MHC ligands contribute to uterine natural killer cell activation during pregnancy in mice.

Felker AM, Chen Z, Foster WG, Croy BA.

Placenta. 2013 Sep;34(9):757-64. doi: 10.1016/j.placenta.2013.06.004. Epub 2013 Jun 24.

PMID:
23806179
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk